Seroprevalence of Toxoplasma Gondii, Rubella and Cytomegalovirus Among Pregnant Women in Our Clinic

To determine the rate of seropositivity in toxoplasma, rubella and cytomegalovirus infections during pregnancy. 4488 pregnants who applied to outpatient polyclinics of Gynecology and Obstetrics in Muğla Sıtkı Koçman University Training and Research Hospital for pregnancy examination in the first 10 weeks of pregnancy were included in the study. Results of anti-Toxoplasma IgM and IgG, anti-Rubella IgM and IgG, anti-CMV IgM and IgG were evaluated. Seropositivity rates of anti-Toxoplasma, anti-Rubella, anti-CMV IgG and IgM were determined respectively 21.6%, 1.6%, 92.8%, 1%; 98.5%, 1.1% in the study group. Toxoplasma, Rubella and CMV seroprevalence should be evaluated during preconceptional or antenatal screening according to regional conditions.